LGC Group

LGC Group is a global life science tools company supplying reference materials, standards, quality control solutions and proficiency testing to customers in pharmaceuticals, clinical diagnostics, food safety and environmental protection. Its LGC Standards division supports measurement quality and regulatory compliance, while LGC Clinical Diagnostics provides quality control and proficiency testing products for laboratories. The company operates multiple manufacturing facilities registered with the EMA, the FDA or equivalent international bodies, and products are sold in over 180 markets.

Beyond standards and controls, LGC supplies components and solutions used in genomics and nucleic acid therapeutics. LGC Biosearch Technologies delivers genomics and nucleic acid-based components, including PCR test components; Axolabs focuses on nucleic acid therapeutics development. During the COVID-19 pandemic the company supplied PCR test components, quality control solutions and proficiency testing to the global public health response.

Founded in 1842, LGC traces its origins to a UK government laboratory and now employs approximately 3,800 people across operations in 14 countries, of whom 1,100 hold advanced degrees. The company states its mission as advancing science for a safer world, with an emphasis on quality, regulatory compliance and collaboration with customers on measurement and testing challenges.